Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors

Among non-small cell lung cancer (NSCLC) patients with therapeutically targetable tumor mutations in epidermal growth factor receptor (EGFR), not all patients respond to targeted therapy. Combining circulating-tumor DNA (ctDNA), clinical variables, and radiomic phenotypes may improve prediction of E...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousefi, Bardia, LaRiviere, Michael J., Cohen, Eric A., Buckingham, Thomas H., Yee, Stephanie S., Black, Taylor A., Chien, Austin L., Noël, Peter, Hwang, Wei-Ting, Katz, Sharyn I., Aggarwal, Charu, Thompson, Jeffrey C., Carpenter, Erica L., Kontos, Despina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113313/
https://www.ncbi.nlm.nih.gov/pubmed/33976268
http://dx.doi.org/10.1038/s41598-021-88239-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113313/
https://www.ncbi.nlm.nih.gov/pubmed/33976268
http://dx.doi.org/10.1038/s41598-021-88239-y

Ejemplares similares